PDGF-B conjugating mesoporous IO/GdO nanocomposites for accurate diagnosis of orthotopic prostatic cancer through T1-T2 dual-modal MRI contrast enhancement

PDGF-B conjugating mesoporous IO/GdO nanocomposites for accurate diagnosis of orthotopic prostatic cancer through T1-T2 dual-modal MRI contrast enhancement

The development of highly efficient magnetic resonance imaging (MRI) contrast agent contributes to the early and accurate diagnosis of cancer. Herein, we developed a novel iron oxide and gadolinium oxide (IO/GdO) nanocomposite as T1-T2 dual modal MRI contrast agent through hydrothermal synthesis met...

Full description

Bibliographic Details
Main Authors: Qingdong Li, Jianmin Xiao, Caiyun Zhang, Peng Wang, Wenling Li, Yinfeng Wang, Lang Ran, Xia Qin, Miao Yan, Junchao Qian, Zhengyan Wu, Geng Tian, Pengfei Wei, Guilong Zhang
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Materials Today Advances
Subjects:
IO/GdO nanocomposite
T1/T2 dual modal MRI
Orthotopic prostate cancer
Accurate diagnosis
Online Access:http://www.sciencedirect.com/science/article/pii/S2590049822000741

Internet

http://www.sciencedirect.com/science/article/pii/S2590049822000741

Similar Items